comparemela.com

Latest Breaking News On - Global product development - Page 16 : comparemela.com

FDA Approves Adjuvant Alectinib for ALK+ Early-Stage NSCLC

The FDA has approved alectinib as adjuvant treatment in select patients with ALK-positive non–small cell lung cancer.

Study Examining Glofitamab With GemOX in Patients With R/R DLBCL Meets Primary Endpoint

Previously, glofitamab had received an accelerated approval for patients with relapsed or refractory diffuse large B-cell lymphoma who received 2 or more prior lines of systemic therapy.

Genentech oncology treatment granted first-of-a-kind approval

Genentech oncology treatment granted first-of-a-kind approval
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.